Germany
Japan
United Kingdom
China
KLRC1 Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Antibodies
View as table Download
HLA-E Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
HLA-E Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
HLA-C Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
KLRD1 Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
HLA-DRB3 Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
HLA-DRB3 Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the N terminal region of human HLA-DRB3 |
HLA-A Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the C terminal region of human HLA-A |
KIR2DL5A Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of human KIR2DL5A |
HLA-DRB1 Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of human HLA-DRB1 |
KIR2DL2 Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the C terminal region of human KIR2DL2 |
HLA-DQA1 Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of human HLA-DQA1 |
KIR3DL1 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human KIR3DL1 ( NP_037421). The exact sequence is proprietary. |
Interferon gamma (IFNG) rabbit polyclonal antibody, Biotin
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Biotin |
| Immunogen | Highly purified recombinant Inferferon gamma. |
Active filters
Category
- Antibodies
Applications
- WB
Antibody Hosts
- Rabbit
Pathways
- Graft-versus-host disease
Filter by
Target Symbol
- CD95 (9)
- IL1 BETA (6)
- IL2 (6)
- NKG2A (6)
- FAS LIGAND (4)
- INTERFERON GAMMA (4)
- TNF ALPHA (4)
- CD94 (3)
- GRANZYME B (3)
- HLA DMB (3)
- HLAA (3)
- IL1 ALPHA (3)
- IL6 (3)
- KIR2DL3 (3)
- KIR3DL1 (3)
- PERFORIN (3)
- HLA DM (2)
- HLA DOB (2)
- HLA DP (2)
- HLA-DOA (2)
- HLA-DPB1 (2)
- HLA-DQA2 (2)
- HLA-DRA (2)
- HLA-DRB1 (2)
- HLA-DRB3 (2)
- HLAB (2)
- HLADQA1 (2)
- HLAE (2)
- HLAF (2)
- KIR2DL5A (2)
- B7-2 (1)
- CD28 (1)
- HLA-DQB1 (1)
- HLA-DRB4 (1)
- HLA-DRB5 (1)
- HLAC (1)
- HLAG (1)
- KIR2DL1 (1)
- KIR2DL2 (1)
- KIR3DL2 (1)